<DOC>
	<DOCNO>NCT02247128</DOCNO>
	<brief_summary>At present , variety antithrombotic regimen prescribe early postprocedure period transcatheter aortic valve implantation ( TAVI ) . Dual antiplatelet therapy ( DAPT ) use aspirin thienopyridine initial period TAVI recommend strategy ; however , mono antiplatelet therapy use aspirin suggest inferior . In patient atrial fibrillation ( AF ) another indication oral anticoagulation ( OAC ) , recommendation best treatment regimen currently exist although triple therapy ( OAC + DAPT ) best avoid due increase bleeding risk . We hypothesise omission clopidogrel first 3 month TAVI safer less beneficial addition clopidogrel aspirin ( cohort A ) OAC ( cohort B ) .</brief_summary>
	<brief_title>Antiplatelet Therapy Patients Undergoing Transcatheter Aortic Valve Implantation</brief_title>
	<detailed_description>The trial consist two cohort : - Cohort A , patient without indication OAC prior TAVI . - Cohort B , patient indication OAC prior TAVI ( eg . atrial fibrillation , mechanic mitral valve prosthesis ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Cohort A 1 . Patient provide write informed consent . Cohort B 1 . Need longterm oral anticoagulation ; 2 . Patient provide write informed consent . Cohort A 1 . Need longterm oral anticoagulation ; 2 . Drugeluting stent implantation within 3 month prior TAVI procedure ; 3 . Baremetal stent implantation within 1 month prior TAVI procedure ; 4 . Allergy intolerance aspirin clopidogrel . Cohort B 1 . Drugeluting stent implantation within 3 month prior TAVI procedure ; 2 . Baremetal stent implantation within 1 month prior TAVI procedure ; 3 . Use nonvitamin K oral anticoagulation ( NOAC ) ; 4 . Allergy intolerance OAC clopidogrel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Transcatheter Aortic Valve Implantation ( TAVI )</keyword>
	<keyword>Transcatheter Aortic Valve Replacement ( TAVR )</keyword>
	<keyword>Aortic Valve Disease</keyword>
	<keyword>Aortic Stenosis</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Embolism Thrombosis</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Prasugrel</keyword>
	<keyword>Ticagrelor</keyword>
	<keyword>Antithrombotic treatment</keyword>
	<keyword>Oral anticoagulation</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Genetic Testing</keyword>
	<keyword>Cytochrome P450 2C19 ( CYP2C19 )</keyword>
	<keyword>Prostaglandin-endoperoxide synthase 2 ( PTGS2 )</keyword>
</DOC>